Mark R. Ziebell
2014
In 2014, Mark R. Ziebell earned a total compensation of $747.4K as Vice President, General Counsel and Corporate Secretary at Peregrine Pharmaceuticals, a 22% increase compared to previous year.
Compensation breakdown
| Bonus | $78,750 |
|---|---|
| Non-Equity Incentive Plan | $109,148 |
| Option Awards | $206,745 |
| Salary | $315,000 |
| Other | $37,772 |
| Total | $747,415 |
Ziebell received $315K in salary, accounting for 42% of the total pay in 2014.
Ziebell also received $78.8K in bonus, $109.1K in non-equity incentive plan, $206.7K in option awards and $37.8K in other compensation.
Rankings
In 2014, Mark R. Ziebell's compensation ranked 8,790th out of 13,032 executives tracked by ExecPay. In other words, Ziebell earned more than 32.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,790 out of 13,032 | 33rd |
Division Manufacturing | 3,273 out of 4,965 | 34th |
Major group Chemicals And Allied Products | 1,112 out of 1,690 | 34th |
Industry group Drugs | 886 out of 1,369 | 35th |
Industry Pharmaceutical Preparations | 675 out of 1,042 | 35th |
Source: SEC filing on August 28, 2014.
Ziebell's colleagues
We found five more compensation records of executives who worked with Mark R. Ziebell at Peregrine Pharmaceuticals in 2014.
2014
Steven King
Peregrine Pharmaceuticals
Chief Executive Officer
2014
Paul Lytle
Peregrine Pharmaceuticals
Chief Financial Officer
2014
Jeffrey Masten
Peregrine Pharmaceuticals
Former Vice President, Quality
2014
Shelley Fussey
Peregrine Pharmaceuticals
Vice President, Intellectual Property
2014
Joseph Shan
Peregrine Pharmaceuticals
Vice President, Clinical & Regulatory Affairs
News
Peregrine Pharmaceuticals CEO Nicholas Green's 2023 pay rises 5% to $6.5M
August 28, 2023
Peregrine Pharmaceuticals CEO Nicholas Green's 2022 pay jumps 117% to $6.2M
August 29, 2022
Peregrine Pharmaceuticals CEO Nicholas Green receives $2.8M in 2021
August 27, 2021
Peregrine Pharmaceuticals General Counsel Mark Ziebell's 2020 pay jumps 124% to $1.1M
August 27, 2020
Peregrine Pharmaceuticals CEO Roger Lias' 2019 pay jumps 25% to $880K
August 21, 2019
Peregrine Pharmaceuticals CEO Roger Lias receives $704K in 2018
August 17, 2018